Magnera’s fourth-quarter results will provide a clearer read on whether the post-merger integration is starting to deliver steadier profitability. The company was formed in November 2024 from the combination of Glatfelter and Berry Global’s Health, Hygiene and Specialties business, creating a global producer of non-woven materials for wipes, personal care, filtration, and healthcare products. Revenue has grown solidly since the merger, yet margins have faced pressure from integration expenses and raw-material inflation. In my view, this release serves as an important checkpoint on whether pricing initiatives and cost synergies are finally gaining traction.
Consensus estimates call for Magnera to post fourth-quarter fiscal 2026 revenue of about $899 million, compared with $839 million in the same period a year earlier. Adjusted EPS is projected near $0.39, a meaningful improvement from the roughly $0.06 adjusted loss recorded last year. Coverage remains limited, so individual forecasts vary and the consensus should be viewed as directional rather than exact. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Management has reaffirmed full-year free-cash-flow guidance of $90 million to $110 million, while indicating that adjusted EBITDA will likely finish at the lower end of the $380 million to $410 million range amid ongoing inflation. Investors will focus on adjusted EBITDA margin, organic sales growth, and evidence that pricing actions are offsetting raw-material costs.
Magnera has missed consensus adjusted EPS in each of the last three quarters, most recently posting an adjusted loss of $0.56 per share versus a $0.31 estimate in the third quarter of fiscal 2026. That pattern has made the shares more reactive to any further shortfalls.
Investor sentiment ahead of the report appears measured. Shares have moved within a wide 52-week range amid uncertainty over the speed of margin recovery and demand trends across end markets. The history of estimate misses has tempered confidence, and prior quarterly releases have produced noticeable price swings. Attention will center on whether pricing measures are closing the gap with raw-material costs, whether the Americas segment continues to lead, and whether European demand shows signs of stabilization. Confirmation or revision of full-year adjusted EBITDA guidance is expected to influence near-term trading.
Beyond the headline numbers, several areas deserve close attention. Pricing versus inflation remains key; management has suggested that most pricing actions should flow through in the fiscal fourth quarter, with only modest lag in international markets. Evidence of that timing would strengthen the case that margin pressure is easing. Cost programs also matter. Magnera has indicated it reached full run-rate benefits from Project CORE and merger synergies in fiscal 2026, with roughly $20 million of run-rate savings expected to carry into fiscal 2027. Progress here, together with the wind-down of transition-services agreements by year-end 2026, should continue to shape the cost base. Demand trends in wipes and infrastructure categories, along with innovation products such as the Universa wipes line, have supported organic growth, while Europe has stayed soft. Free cash flow generation and disciplined capital spending remain priorities for management. These elements, more than any single quarterly figure, will likely shape how investors assess Magnera’s story in the quarters ahead.
When preparing for earnings like this one, I find it useful to run quick comparisons across the sector. Tickeron’s AI Screener lets me apply technical and fundamental filters to narrow the list efficiently and surface names that share similar characteristics with MAGN. It has become a regular part of my workflow for identifying context around upcoming reports.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for MAGN crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on MAGN as a result. In 65 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for MAGN just turned positive on October 22, 2026. Looking at past instances where MAGN's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.
MAGN moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where MAGN advanced for three days, in 188 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for MAGN moved below the 200-day moving average on October 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MAGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
MAGN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MAGN entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.374) is normal, around the industry mean (21.072). P/E Ratio (-0.622) is within average values for comparable stocks, (16.552). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (1.518). Dividend Yield (0.074) settles around the average of (0.033) among similar stocks. P/S Ratio (0.129) is also within normal values, averaging (1.902).
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. MAGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MAGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of papers and fiber-based engineered materials
Industry HouseholdPersonalCare